Omega Healthcare Investors (OHI) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
29 Apr, 2026Executive summary
Net income for Q1 2026 was $159 million ($0.47 per share), up from $112 million ($0.33 per share) in Q1 2025, reflecting strong revenue and EBITDA growth from acquisitions and portfolio management.
Adjusted FFO (AFFO) was $0.82 per share and FAD was $0.78 per share, both up year-over-year, with FAD per share increasing 9.5%.
Dividend payout ratios dropped to 82% for AFFO and 86% for FAD, with a quarterly dividend of $0.67 per share declared.
Active portfolio management included $251 million in new investments and planned asset sales generating $480 million in proceeds, with expected AFFO and FAD accretion.
Investments spanned triple net and RIDEA structures in skilled nursing, senior housing, and long-term care across the U.S., U.K., and Canada.
Financial highlights
Q1 2026 revenue was $323 million, up from $277 million in Q1 2025, driven by new investments and annual escalators.
Rental income rose to $270.6 million, interest income reached $45.2 million, and Nareit FFO was $249.5 million.
Adjusted FFO was $260 million ($0.82 per share); FAD was $247 million ($0.78 per share), both $0.02 higher sequentially from Q4.
Total assets at quarter-end were $10.2 billion; total equity $5.5 billion; total debt $4.5 billion (45.1% of capitalization).
Operating cash flow increased to $215.5 million from $182.0 million year-over-year.
Outlook and guidance
Full-year 2026 Adjusted FFO guidance narrowed to $3.19–$3.25 per share, with the midpoint raised by $0.02.
Guidance includes completed investments as of April 27, scheduled loan repayments, and expected asset sales, but excludes additional investments not outlined in the press release.
Management remains cautious due to staffing shortages, inflation, and regulatory uncertainty, but expects sufficient liquidity and capital resources for operations and investments.
Latest events from Omega Healthcare Investors
- Proxy details strong 2025 results, performance-based pay, and leadership in ESG and governance.OHI
Proxy filing21 Apr 2026 - Key votes include director elections, auditor ratification, and executive pay approval.OHI
Proxy filing21 Apr 2026 - Strong Q4 and 2025 results, major investments, and a positive 2026 outlook with low leverage.OHI
Q4 202513 Apr 2026 - Consistent high-yield growth, strong financials, and demographic tailwinds drive expansion.OHI
Investor presentation5 Feb 2026 - Q2 net income and FFO rose, AFFO guidance increased, but operator and regulatory risks remain.OHI
Q2 20242 Feb 2026 - Q3 FAD and net income rose, AFFO guidance raised, but operator and regulatory risks persist.OHI
Q3 202417 Jan 2026 - Q4 delivered strong growth, decade-low leverage, and a robust 2025 outlook with U.K. investments.OHI
Q4 20248 Jan 2026 - Q1 2025 net income and AFFO rose sharply, driving higher guidance and robust investments.OHI
Q1 202525 Dec 2025 - Board recommends FOR all proposals, citing strong performance and enhanced ESG focus.OHI
Proxy Filing1 Dec 2025